
India’s generic medicines steal the spotlight as US exempts pharma from tariffs
India’s pharma sector has emerged as a big winner amid Trump’s tariff woes, as the US has exempted pharmaceuticals from reciprocal tariffs, recognizing the vital role of India’s generic medicines in global healthcare. This decision comes amid US President Donald Trump’s announcement of 27 percent tariffs on imports from about 60 countries, including India, in…